Skip to main navigation Skip to search Skip to main content

MQX‐503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: A randomized, controlled trial

  • Naomi Rothfield
  • , Lee Shapiro
  • , David Fiorentino
  • , Lorinda Chung
  • , Christopher Denton
  • , Ariane Herrick
  • , Murray Baron
  • , Joseph Shanahan
  • , Vivien Hsu
  • , Jill Belch
  • , Virginia Steen
  • , Agneta Scheja
  • , Richard Martin
  • , Edwin Smith
  • , Maureen Mayes
  • , Robert Simms
  • , Janet Pope
  • , Bashar Kahaleh
  • , Mary Ellen Csuka
  • , Barry Gruber
    • David Collier, Nadera Sweiss, Sangeeta Sule, Paul Emery, Fredrick M. Wigey

    Research output: Contribution to journal › Book/Film/Article review › peer-review

    Fingerprint

    Dive into the research topics of 'MQX‐503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: A randomized, controlled trial'. Together they form a unique fingerprint.
    Sort by

    Keyphrases

    Pharmacology, Toxicology and Pharmaceutical Science